Azithromycin for Hospitalized Children with Asthma Symptoms

We are studying whether a three-day treatment with azithromycin helps young children aged 1-5 years who are hospitalized due to asthma-like symptoms. This research may lead to better, personalized treatments based on individual responses.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Azithromycin
Azithromycin is an antibiotic substance used to treat common bacterial infections, especially respiratory, ear, skin, and some sexually transmitted infections.
Sodium Phosphate Dodecahydrate
Sodium phosphate dodecahydrate is a salt that helps clear the bowels by causing watery stools for colon cleansing before procedures.
Sucrose
Sucrose is a common sugar used as a sweetener and a quick source of energy.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Banana Flavour
Xanthum Gum
Hydroxypropyl Cellulose

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Aarhus Universitetshospital
Børne Center for Lunge- og Allergisygdomme, Børn og Unge Klinik 1
Århus, Denmark
Gentofte Hospital
Pediatric department
Charlottenlund, Denmark
Lillebaelt Hospital
Pediatric department
Kolding, Denmark
Sponsor: Herlev and Gentofte Hospital, Copenhagen Prospective Studies on Asthma in Childhood (COPSAC)
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.